Raven Biomaterials

Raven Biomaterials is a private U.S. biotechnology and life science tools company developing magnetic bead-based cell separation products for cell therapy manufacturing and patient monitoring. Its core RBI-beads platform uses dense metallic immunomagnetic microparticles designed to improve speed, purity, and especially recovery of desired cells from blood, PBMC, and leukapheresis samples. The company positions the technology as a way to improve starting material quality for CAR-T, NK-cell, and T-cell receptor therapy workflows while reducing processing time, blood draw burden, and manufacturing cost. Raven Biomaterials appears to market research-use products directly through its website and has also received NIH SBIR support to expand and automate its cell enrichment approach. The company is founder-led by Caroline Hoedemaker and operates out of the Ben Franklin TechVentures facility in Bethlehem, Pennsylvania, with legal/company registration tied to Pennington, New Jersey.